indazoles has been researched along with 1H-indazol-3-amine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamborough, P; Brown, MJ; Christopher, JA; Chung, CW; Mellor, GW | 1 |
| Dong, J; Dong, Y; Pan, X; Shan, Y; Wang, M; Zhang, J; Zhang, L | 1 |
| Ai, J; Cui, J; Dai, Y; Gao, D; Li, Y; Peng, X | 1 |
| Li, C; Pan, X; Shan, Y; Si, R; Sun, Y; Wang, B; Zhang, J | 1 |
| Abarbri, M; El Qami, A; Frlan, R; Gobec, S; Jismy, B; Knez, D; Kos, J; Pišlar, A | 1 |
5 other study(ies) available for indazoles and 1H-indazol-3-amine
| Article | Year |
|---|---|
Selectivity of kinase inhibitor fragments.
Topics: Adenine; Adenosine Triphosphate; Aniline Compounds; Binding Sites; Enzyme Inhibitors; High-Throughput Screening Assays; Indazoles; Indoles; Isoenzymes; Models, Molecular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; Pyrimidines; Quantitative Structure-Activity Relationship; Small Molecule Libraries | 2011 |
Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; Indazoles; K562 Cells; Molecular Docking Simulation; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Structure-Activity Relationship | 2015 |
Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indazoles; Models, Molecular; Molecular Structure; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Structure-Activity Relationship | 2017 |
Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Molecular Docking Simulation; Molecular Structure; Neovascularization, Pathologic; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Thiourea | 2017 |
Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Topics: Antiparkinson Agents; Bromides; Coordination Complexes; Humans; Indazoles; Metals; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Protein Binding; Small Molecule Libraries; Structure-Activity Relationship; Tyramine | 2021 |